Processing

Please wait...

Settings

Settings

Goto Application

1. WO2014128228 - MEDICAMENT

Publication Number WO/2014/128228
Publication Date 28.08.2014
International Application No. PCT/EP2014/053365
International Filing Date 20.02.2014
IPC
A61K 8/44 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8Cosmetics or similar toilet preparations
18characterised by the composition
30containing organic compounds
40containing nitrogen
44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts, esters or N-acylated derivatives thereof
A61Q 17/04 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
17Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
CPC
A61K 2800/592
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
2800Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
40Chemical, physico-chemical or functional or structural properties of particular ingredients
59Mixtures
592Mixtures of compounds complementing their respective functions
A61K 2800/782
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
2800Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
74Biological properties of particular ingredients
78Enzyme modulators, e.g. Enzyme agonists
782Enzyme inhibitors; Enzyme antagonists
A61K 8/26
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8Cosmetics or similar toilet preparations
18characterised by the composition
19containing inorganic ingredients
26Aluminium; Compounds thereof
A61K 8/29
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8Cosmetics or similar toilet preparations
18characterised by the composition
19containing inorganic ingredients
29Titanium; Compounds thereof
A61K 8/31
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8Cosmetics or similar toilet preparations
18characterised by the composition
30containing organic compounds
31Hydrocarbons
A61K 8/345
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
8Cosmetics or similar toilet preparations
18characterised by the composition
30containing organic compounds
33containing oxygen
34Alcohols
345containing more than one hydroxy group
Applicants
  • SYMRISE AG [DE]/[DE] (AllExceptUS)
  • VIELHABER, Gabriele [DE]/[FR] (US)
  • LE MAIRE, Marielle [FR]/[FR] (US)
Inventors
  • VIELHABER, Gabriele
  • LE MAIRE, Marielle
Agents
  • FABRY, Bernd
Priority Data
13156181.321.02.2013EP
Publication Language German (de)
Filing Language German (DE)
Designated States
Title
(DE) MEDIKAMENT
(EN) MEDICAMENT
(FR) MÉDICAMENT
Abstract
(DE) Vorgeschlagen wird ein Medikament enthaltend (a) mindestens eine Verbindung der Formel (I) mit der Maßgabe, dass R1 für H oder CH3 und R2 für H oder COOH steht, oder deren Salze, und (b) mindestens einen UV-Lichtschutzfaktor zur Inhibierung der durch UV-Strahlung induzierten MMP-1-Expression.
(EN) The invention relates to a medicament containing (a) at least one compound of formula (I), where R1 represents H or CH3 and R2 represents H or COOH, or the salts thereof, and (b) at least one UV radiation protection factor for inhibiting MMP-1 expression caused by UV radiation.
(FR) L'invention concerne un médicament, contenant (a) au moins un composé de formule (I), à condition que R1 représente H ou CH3 et R2 représente H ou COOH, ou ses sels et (b) au moins un facteur de protection contre la lumière UV pour inhiber l'expression de MMP-1 induite par le rayonnement UV.
Related patent documents
Latest bibliographic data on file with the International Bureau